References
Additional Protocol to the Convention on Human Rights and Biomedicine, concerning Genetic
Testing for Health Purposes (2008), CETS No. 203
Agency for Health Care Research and Quality (AHRQ) (2001) Reducing and preventing adverse
drug events to decrease hospital costs. Research in Action, Issue 1.http://archive.ahrq.gov/
research/findings/factsheets/errors-safety/aderia/ade.html. Accessed 13 Jun 2014
Bottinger EP (2007) Foundations, promises and uncertainties of personalized medicine. Mount
Sinai J Med 74:15–21
Centers for Medicare & Medicaid Services (CMS) (2015)https://www.cms.gov/Regulations-and-
Guidance/Legislation/CLIA/index.html?redirect¼/clia. Accessed 10 Jan 2015
Charter of Fundamental Rights of the EU, OJ C 83 of 30.03.2010
Constitution of the Republic of Croatia, Official Gazette of the Republic of CroatiaNarodne
novinenos. 56/90, 135/97, 8/98, 113/00, 124/00, 28/01, 41/01, 55/01, 76/10, 85/10 and 05/14
Constitution of the World Health Organisation (1946) Basic Documents, Supplement 2006,http://
http://www.who.int/governance/eb/who_constitution_en.pdf. Accessed 10 Mar 2014
Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the
Application of Biology and Medicine (1997) CETS No. 164
Convention for the Protection of Human Rights and Fundamental Freedoms (1950) CETS No. 005
Council Directive 2000/43/EC of 29 June 2000 implementing the principle of equal treatment
between persons irrespective of racial or ethnic origin, OJ L 180 of 19.07.2000
Damm R (2007) Gendiagnostik als Gesetzgebungsprojekt. Regelungsinitiativen und
Regelungsschwerpunkte. Bundesgesundheitsblatt – Gesundheitsforschung –
Gesundhetisschutz 50(2):145–156
Damm R (2009) Pra ̈diktive Gesundheitsinformationen, Pers€onlichkeitsrechte und Drittinteressen:
Prinzipiendiskussion und Rechtspolitik. In: Ciacchi C et al (eds) Haftungsrecht im dritten
Millenium. Liber Amicorum Gert Br€uggemeier. Nomos, Baden-Baden, pp 303–330
Damm R (2011) Personalisierte Medizin und Patientenrechte – Medizinische Optionen und
medizinrechtliche Bewertung. MedR 29:7–17
Damm R, K€onig S (2008) Rechtliche Regulierung pra ̈diktiver Gesundheitsinformationen und
genetischer Exzeptionalismus. MedR 26(2):62–70
Deutscher Bundestag (2009) Bericht des Ausschusses f€ur Bildung, Forschung und
Technikfolgenabscha ̈tzung: Zukunftsreport Individualisierte Medizin und Gesundheitssystem.
Drucksache 16/2000 of 17.02.2009
Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the
approximation of the laws, regulations and administrative provisions of the Member States
relating to the implementation of good clinical practice in the conduct of clinical trials on
medicinal products for human use, OJ L 121 of 01.05.2001
Directive 2001/83/EC on the Community code relating to medicinal products for human use, OJ L
311 of 28.11.2001
Directive 2006/54/EC of the European Parliament and of the Council of 5 July 2006 on the
implementation of the principle of equal opportunities and equal treatment of men and women
in matters of employment and occupation (recast), OJ L 204 of 26.07.2006
Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the
protection of individuals with regard to the processing of personal data and on the free
movement of such data, OJ L 281/31 of 23.11.1995
Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro
diagnostic medical devices, OJ L 331 of 07.12.1998.
Duke Center for Personalized and Precision Medicine (2015)http://dukepersonalizedmedicine.
org/policy/regulatorylegal. Accessed 20 Jan 2015
Dulcˇic ́K, Bodiroga-Vukobrat N (2008) Zasˇtita osobnih podataka pacijenata u europskom i
hrvatskom pravu. Zb Prav fak SveucˇRij 29(1):371–411
Challenges of Personalized Medicine: Socio-Legal Disputes and Possible Solutions 49